Please Wait
Applying Filters...
menu
    • menu
    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Dexlansoprazole

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 252Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alembic Gets USFDA Nod For Dexlansoprazole Delayed-Release
    Alembic Gets USFDA Nod For Dexlansoprazole Delayed-Release

    13 Nov 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/alembic-receives-usfda-approval-for-dexlansoprazole-delayed-release-capsules/

    EXPRESSPHARMA
    13 Nov 2025
    Share Share
    Alembic’s Generics Dexlansoprazole Receives Approval In US
    Alembic’s Generics Dexlansoprazole Receives Approval In US

    12 Nov 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219115

    FDA
    12 Nov 2025
    Share Share
    Altius, Launches Authorized Generic of Dexlansoprazole (Dexilant®) in Canada
    Altius, Launches Authorized Generic of Dexlansoprazole (Dexilant®) in Canada

    27 Feb 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240227281018/en

    BUSINESSWIRE
    27 Feb 2024
    Share Share
    TWi's Generic Dexlansoprazole Receives Approval in the U.S.
    TWi's Generic Dexlansoprazole Receives Approval in the U.S.

    16 Sep 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202666

    FDA
    16 Sep 2022
    Share Share
    Par Pharm’s Generic Dexlansoprazole Receives Approval In US
    Par Pharm’s Generic Dexlansoprazole Receives Approval In US

    20 Apr 2017

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202294

    FDA
    20 Apr 2017
    Share Share
    Takeda’s Dexlansoprazole Received Approval In US
    Takeda’s Dexlansoprazole Received Approval In US

    26 Oct 2016

    // FDA

    https://www.pharmacompass.com/pdf/news/takedas-dexlansoprazole-received-approval-in-us-1477649737.pdf

    FDA
    26 Oct 2016
    Share Share